|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3895 EUR | -0.13% |
|
-1.14% | -15.33% |
| 05-07 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
| 04-05 | GenSight: financial visibility assured until the end of April | CF |
GenSight Biologics S.A. announced a private placement of common shares at a price of ?0.025 for the gross proceeds of ?1,546,199.455 on May 7, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.33% | 42.92M | |
| +12.30% | 118B | |
| +12.15% | 106B | |
| -8.14% | 23.4B | |
| -1.69% | 21.78B | |
| -10.60% | 18.09B | |
| -41.25% | 16.72B | |
| -15.33% | 15.97B | |
| +5.80% | 14.03B | |
| +28.03% | 11.67B |
GENSIGHT BIOLOGICS S.A. 
